Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Kamel Khalili
Drexel University, Department: Microbiology/immun/virology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Excision BioTherapeutics
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Khalili is a founding member, scientific advisory board member and IP holder of a privately held company called Excision BioTherapeutics. The company is currently working on commercializing their technology and there is no dollar amount awarded to it yet. Dr. Khalili has indicated that the research being conducted on this project relates to the technology.
Gene editing strategies to target HIV for elimination in periphery and brain
Current antiretroviral therapy has failed to eradicate HIV-1, partly due to the persistence of viral reservoirs including CD4+ T lymphocytes, cells of the monocyte-macrophage lineage, and other central nervous system cells. We propose to develop precise and personalized gene editing strategies to eradicate HIV-1 from these cells from a cohort of HIV-1 infected patients as a first step toward a cure for this disease.
Filed on March 06, 2017.
Tell us what you know about Kamel Khalili's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Kamel Khalili filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Kamel Khalili | Florida International University | Conflict of Interest | Excision BioTherapetuics, LLC | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.